240593

Boston, Massachusetts 02215

0 studies enrolling now · 1 studies all time

What they study most

Multiple Myeloma

Studies at this site

• Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Nirogacestat in Participants With RRMM — Running, not enrolling